| 1 |
Powell C, Chang C, Naguwa SM, et al. Steroid induced osteonecrosis: An analysis of steroid dosing risk[J]. Autoimmun Rev, 2010, 9(11): 721-743.
|
| 2 |
Jones LC, Mont MA, Le TB, et al. Procoagulants and osteonecrosis[J]. J Rheumatol, 2003, 30(4): 783-791.
|
| 3 |
Jones JP Jr. Coagulopathies and osteonecrosis[J]. Acta Orthop Belg, 1999, 65 Suppl 1: 5-8.
|
| 4 |
Chandler FA . Coronary disease of the hip[J]. J Int Coll Surg, 1948, 11(1): 34-36.
|
| 5 |
刘耀升，刘蜀彬. 早中期股骨头坏死的非手术治疗进展[J/CD]. 中华损伤与修复杂志：电子版，2012, 7(6): 668-670.
|
| 6 |
Hayashi S, Fujioka M, Ikoma K, et al. Evaluation of femoral perfusion in a rabbit model of steroid-induced osteonecrosis by dynamic contrast-enhanced mri with a high magnetic field MRI system[J]. J Magn Reson Imaging, 2015, 41(4): 935-940.
|
| 7 |
Janke LJ, Liu C, Vogel P, et al. Primary epiphyseal arteriopathy in a mouse model of steroid-induced osteonecrosis[J]. Am J Pathol, 2013, 183(1): 19-25.
|
| 8 |
Kerachian MA, Séguin C, Harvey EJ. Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action[J]. J Steroid Biochem Mol Biol, 2009, 114(3-5): 121-128.
|
| 9 |
Tian L, Zhou DS, Wang KZ, et al. Association of toll-like receptor 4 signaling pathway with steroid-induced femoral head osteonecrosis in rats[J]. J Huazhong Univ Sci Technolog Med Sci, 2014, 34(5): 679-686.
|
| 10 |
Tian L, Wen Q, Dang X, et al. Immune response associated with Toll-like receptor 4 signaling pathway leads to steroid-induced femoral head osteonecrosis[J]. BMC Musculoskelet Disord, 2014, 15: 18.
|
| 11 |
Weinstein RS, Nicholas RW, Manolagas SC. Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip[J]. J Clin Endocrinol Metab, 2000, 85(8): 2907-2912.
|
| 12 |
Calder JD, Buttery L, Revell PA, et al. Apoptosis-a significant cause of bone cell death in osteonecrosis of the femoral head[J]. J Bone Joint Surg Br, 2004, 86(8): 1209-1213.
|
| 13 |
Wang L, Luo DK, Pan ZY. Expression of 11β-HSD in steroid-induced avascular necrosis of the femoral head[J]. Mol Med Rep, 2013, 7(5): 1482-1486.
|
| 14 |
Wu X, Yang S, Wang H, et al. G-CSF/SCF exert beneficial effects via anti-apoptosis in rabbits with steroid-associated osteonecrosis[J]. Exp Mol Pathol, 2013, 94(1): 247-254.
|
| 15 |
Tian L, Dang XQ, Wang CS, et al. Effects of sodium ferulate on preventing teroid-induced femoral head osteonecrosis in rabbits[J]. J Zhejiang Univ Sci B, 2013, 14(5): 426-437.
|
| 16 |
Moriishi T, Maruyama Z, Fukuyama R, et al. Overexpression of Bcl2 in osteoblasts inhibits osteoblast differentiation and induces osteocyte apoptosis[J]. PLoS One, 2011, 6(11): e27487.
|
| 17 |
Ookawa K, Tsuchida S, Adachi J, et al. Differentiation induced by RB expression and apoptosis induced by p53 expression in an osteosarcoma cell line[J]. Oncogene, 1997, 14(12): 1389-1396.
|
| 18 |
Kogianni G, Mann V, Ebetino F, et al. Fas/CD95 is associated with glucocorticoidinduced osteocyte apoptosis[J]. Life Sci, 2004, 75(24): 2879-2895.
|
| 19 |
Samara S, Dailiana Z, Chassanidis C, et al. Expression profile of osteoprotegerin RANK and RANKL genes in the femoral head of patients with avascular necrosis[J]. Exp Mol Pathol, 2014, 96(1): 9-14.
|
| 20 |
Weinstein RS, Jilka RL, Parfitt AM, et al. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone[J]. J Clin Invest, 1998, 102(2): 274-282.
|
| 21 |
Kerachian MA, Harvey EJ, Cournoyer D, et al. Avascular necrosis of the femoral head: vascular hypotheses[J]. Endothelium, 2006, 13(4): 237-244.
|
| 22 |
Feng Y, Yang SH, Xiao BJ, et al. Decreased in the numbe and function of circulation endothelial progenitor cells in patients with avascular necrosis of the femoral head[J]. Bone, 2010, 46(1): 32-40.
|
| 23 |
Li YM, Wang SX, Gao HS, et al. Factors of avascular necrosis of femoral head and osteoporosis in SARS patients' convalescence[J]. Zhonghua Yi Xue Za Zhi, 2004, 84(16): 1348-1353.
|
| 24 |
Ferrari P, Schroeder V, Anderson S, et al. Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients[J]. Transplantation, 2002, 74(8): 1147-1152.
|
| 25 |
Li C, Shen L, Yang Y, et al. Plasma ghrelin and von Willebrand Factor levels in patients with non-traumatic osteonecrosis of the femoral head[J]. Hip Int, 2015, 25(1): 76-81.
|
| 26 |
Kang P, Shen B, Yang J, et al. Circulating platelet-derived microparticles and endothelium-derived microparticles may be a potential cause of microthrombosis in patients with osteonecrosis of the femoral head[J]. Thromb Res, 2008, 123(2): 367-373.
|
| 27 |
Wu Z, Ji C, Li H, et al. Elevated level of membrane microparticles in the disease of steroid-induced vascular osteonecrosis[J]. J Craniofac Surg, 2013, 24(4): 1252-1256.
|
| 28 |
Chotanaphuti T, Heebthamai D, Chuwong M, et al. The prevalence of thrombophilia in idiopathic osteonecrosis of the hip[J]. J Med Assoc Thai, 2009, 92 Suppl 6: S141-S146.
|
| 29 |
Glueck CJ, Freiberg RA, Boppana S, et al. Thrombophilia, hypofibrinolysis, the eNOS T-786 C polymorphism, and multifocal osteonecrosis[J]. J Bone Joint Surg Am, 2008, 90(10): 2220-2229.
|
| 30 |
Glueck CJ, Freiberg RA, Wang P. Heritable thrombophilia-hypofibrinolysis and osteonecrosis of the femoral head[J]. Clin Orthop Relat Res, 2008, 466(5): 1034-1040.
|
| 31 |
Yamaguchi R1, Yamamoto T, Motomura G, et al. Effects of an anti-platelet drug on the prevention of steroid-induced osteonecrosis in rabbits[J]. Rheumatology (Oxford), 2012, 51(1): 789-793.
|
| 32 |
Arlet J, Ficat P, Lartigue G, et al. Clinical research on intraosseous pressure in the upper femoral metaphysis and epiphysis in humans. Application to the diagnosis of ischemia and necrosis[J]. Rev Rhum Mal Osteo-artic, 1972, 39(11): 717-723.
|
| 33 |
Cheng X, Hu B, Sheng J, et al. [Preliminary analysis of differentially expressed genes in steroid-induced osteonecrosis of femoral head by gene microarray][J]. Zhong guo Xiu Fu Chong Jian Wai Ke Za Zhi, 2014, 28(5): 586-590.
|
| 34 |
Wang KZ, Wang CS, Wu YG, et al. [Changes of vessel in steroid-induced osteonecrosis of femoral head: experimental study of rabbits][J]. Zhong hua Yi Xue Za Zhi, 2006, 86(29): 2024-2027.
|
| 35 |
Atsumi T, Kuroki Y. Role of impairment of blood supply of the femoral head in the pathogenesis of idiopathic osteonecrosis[J]. Clin Orthop Relat Res, 1992, 277: 22-30.
|
| 36 |
Welch RD, Johnston CE 2nd, Waldron MJ, et al. Bone changes associated with intraosseous hypertension in the caprine tibia[J]. J Bone Joint Surg Am, 1993, 75(1): 53-60.
|
| 37 |
Harada I. [The effects of glucocorticoids on angiogenesis in vitro][J]. Nihon Seikeigeka Gakkai Zasshi, 1992, 66(7): 763-770.
|
| 38 |
Li J, Fan L, Yu Z, et al. The effect of deferoxamine on angiogenesis and bone repair in steroid-induced osteonecrosis of rabbit femoral heads[J]. Exp Biol Med (Maywood), 2015, 240(2): 273-280.
|
| 39 |
Yang C, Yang S, Du J, et al. Experimental study of vascular endothelial growth factor gene therapy for avascular necrosis of the femoral head[J]. J Huazhong Univ Sci Technolog Med Sci, 2003, 23(297-299): 316.
|
| 40 |
Lee YJ, Lee JS, Kang EH, et al. Vascular endothelial growth factor polymorphisms in patients with steroid-induced femoral head osteonecrosis[J]. J Orthop Res, 2012, 30(1): 21-27.
|
| 41 |
Ikemura S, Yamamoto T, Motomura G, et al. Preventive effects of the anti-vasospasm agent via the regulation of the Rho-kinase pathway on the development of steroid-induced osteonecrosis in rabbits[J]. Bone, 2013, 53(2): 329-335.
|
| 42 |
Ichiseki T, Matsumoto T, Nishino M, et al. Oxidative stress and vascular permeability in steroidinduced osteonecrosis model[J]. J Orthop Sci, 2004, 9(5): 509-515.
|
| 43 |
Ichiseki T, Matsumoto T. Oxidative stress may underlie the sex differences seen in steroid-induced osteonecrosis models[J]. Med Hypotheses, 2006, 66(6): 1256.
|
| 44 |
Song Q, Shi Z, Bi W, et al. Beneficial effect of grape seed proanthocyanidin extract in rabbits with steroid-induced osteonecrosis via protecting against oxidative stress and apoptosis[J]. J Orthop Sci, 2015, 20(1): 196-204.
|
| 45 |
Li GY, Feng Y, Cheng TS, et al. Edaravone, a novel free radical scavenger, prevents steroid-induced osteonecrosis in rabbits[J]. Rheumatology (Oxford), 2013, 52(3): 438-447.
|
| 46 |
Kömürcü E, Oktay M, Kaymaz B, et al. Preventive effects of coenzyme Q10 (CoQ10) on steroid-induced osteonecrosis in rats[J]. Acta Orthop Traumatol Turc, 2014, 48(2): 217-222.
|
| 47 |
Jaffe WL, Epstein M, Heyman N, et al. The effect of cortisone on femoral and humeral heads in rabbits. An experimental study[J]. Clin Orthop Relat Res, 1972, 82: 221-228.
|
| 48 |
Chen XC, Weng J, Chen XQ, et al. Relationships among magnetic resonance imaging, histological findings, and IGF-I in steroid-induced osteonecrosis of the femoral head in rabbits[J]. J Zhejiang Univ Sci B, 2008, 9(9): 739-746.
|
| 49 |
Li W, Wang X, Liu B, et al. [Preventing steroid-induced osteonecrosis of the femoral head with Liuwei dihuang pills and molecular mechanism][J]. Zhong guo Xiu Fu Chong Jian Wai Ke Za Zhi, 2010, 24(4): 446-451.
|
| 50 |
Ding S, Peng H, Fang HS, et al. Pulsed electromagnetic fields stimulation prevents steroid-induced osteonecrosis in rats[J]. BMC Musculoskelet Disord, 2011, 12: 215.
|
| 51 |
Motomura G, Yamamoto T, Irisa T, et al. Dose effects of corticosteroids on the development of osteonecrosis in rabbits[J]. J Rheumatol, 2008, 35(12): 2395-2399.
|
| 52 |
Motomura G, Yamamoto T, Miyanishi K, et al. Risk factors for developing osteonecrosis after prophylaxis in steroid-treated rabbits[J]. J Rheumatol, 2008, 35(12): 2391-2394.
|
| 53 |
Kaneshiro Y, Oda Y, Iwakiri K, et al. Low hepatic cytochrome P450 3A activity is a risk for corticosteroid-induced osteonecrosis[J]. Clin Pharmacol Ther, 2006, 80(4): 396-402.
|
| 54 |
Masada T, Iwakiri K, Oda Y, et al. Increased hepatic cytochrome P4503A activity decreases the risk of developing steroid-induced osteonecrosis in a rabbit model[J]. J Orthop Res, 2008, 26(1): 91-95.
|
| 55 |
Tokuhara Y, Wakitani S, Oda Y, et al. Low levels of steroid-metabolizing hepatic enzyme (cytochrome P450 3A) activity may elevate responsiveness to steroids and may increase risk of steroid-induced osteonecrosis even with low glucocorticoid dose[J]. J Orthop Sci, 2009, 14(6): 794-800.
|
| 56 |
Wang Z, Zhang Y, Kong X, et al. Association of a polymorphism in PON-1 gene with steroid-induced osteonecrosis of femoral head in Chinese Han population[J]. Diagn Pathol, 2013, 8: 186.
|
| 57 |
Zhang Y, Wang R, Li S, et al. Genetic polymorphisms in plasminogen activator inhibitor-1 predict susceptibility to steroid-induced osteonecrosis of the femoral head in Chinese population[J]. Diagn Pathol, 2013, 8: 169.
|
| 58 |
Zhang Y, Kong X, Wang R, et al. Genetic association of the P-glycoprotein gene ABCB1 polymorphisms with the risk for steroid-inducedosteonecrosis of the femoral head in Chinese population[J]. Mol Biol Rep, 2014, 41(5): 3135-3146.
|
| 59 |
Ma XL, Liu ZP, Ma JX, et al. Dynamic expression of Runx2, Osterix and AJ18 in the femoral head of steroid-induced osteonecrosis in rats[J]. Orthop Surg, 2010, 2(4): 278-284.
|
| 60 |
Tong P, Wu C, Jin H, et al. Gene expression profile of steroid-induced necrosis of femoral head of rats[J]. Calcif Tissue Int, 2011, 89(4): 271-284.
|
| 61 |
Asano T, Takahashi KA, Fujioka M, et al. ABCB1 C3435T and G2677T/A polymorphism decreased the risk for steroidinduced osteonecrosis of the femoral head after kidney transplantation[J]. Pharmacogenetics, 2003, 13(11): 675-682.
|
| 62 |
Han N, Yan Z, Guo CA, et al. Effects of p-glycoprotein on steroid-induced osteonecrosis of the femoral head[J]. Calcif Tissue Int, 2010, 87(3): 246-253.
|
| 63 |
Zheng L, Wang W, Ni J, et al. Plasma interleukin 33 level in patients with osteonecrosis of femoral head: an alarmin for osteonecrosis of the femoral head[J]. J Investig Med, 2014, 62(3): 635-637.
|
| 64 |
Cuadrado MJ, Lopez-Pedrera C. Antiphospholipid syndrome[J]. Clin Exp Med, 2003, 3(3): 129-139.
|
| 65 |
Bekler H, Uygur AM, Gökçe A, et al. [The effect of steroid use on the pathogenesis of avascular necrosis of the femoral head: an animal model][J]. Acta Orthop Traumatol Turc, 2007, 47(1): 58-63.
|
| 66 |
Matsui M, Saito S, Ohzono K, et al. Experimental steroid-induced osteonecrosis in adult rabbits with hypersensitivity vasculitis[J]. Clin Orthop Relat Res, 1992, (277): 61-72.
|
| 67 |
Aimaiti A, Wufuer M, Wang YH, et al. Can bisphenol A diglycidyl ether (BADGE) administration prevent steroid-induced femoral head osteonecrosis in the early stage[J]. Med Hypotheses, 2011, 77(2): 282-285.
|
| 68 |
Li J, Li Y, Wang Y, et al. Preventive effects of siRNA targeting PPARγ gene on steroid-induced osteonecrosis in rabbits[J]. Connect Tissue Res, 2014, 55(5-6): 322-330.
|
| 69 |
Jiang Y, Liu D, Kong X, et al. Huogu I formula prevents steroid-induced osteonecrosis in rats by down-regulating PPARgamma expression and activating wnt/LRP5/beta-catenin signaling[J]. J Tradit Chin Med, 2014, 34(3): 342-350.
|
| 70 |
Jiang Y, Zhang Y, Zhang H, et al. Pravastatin prevents steroid-induced osteonecrosis in rats by suppressing PPAR γ expression and activating Wnt signaling pathway[J]. Exp Biol Med (Maywood), 2014, 239(3): 347-335.
|